An Open Label, Multicenter, Single-arm Trial to Assess Safety and Efficacy of Alteplase (Rt-PA) in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 13 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Oct 2017.
- 13 Jan 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.
- 16 Dec 2016 Status changed from not yet recruiting to recruiting.